Results 131 to 140 of about 1,792,432 (255)

Surgical considerations based on oral and periodontal vascularization

open access: yesPeriodontology 2000, EarlyView.
Abstract Objectives To synthesize current evidence on vascular and anastomotic patterns, emphasizing their operative implications for optimizing flap perfusion, neovascularization, and wound healing in periodontal and implant surgery, while accounting for anatomical variability and collateral circulation. Materials and Methods A comprehensive review of
Arvin Shahbazi   +5 more
wiley   +1 more source

Contemporary zygomatic implant rehabilitation: A critical review of the evidence and clinical recommendations

open access: yesPeriodontology 2000, EarlyView.
Abstract Background Zygomatic implant (ZI) therapy has evolved over the past two decades into an established modality for the rehabilitation of the severely atrophic maxilla, avoiding extensive bone augmentation procedures. Aim While the efficacy of ZI therapy is well established, variability in its clinical implementation and remaining knowledge gaps ...
Shengchi Fan   +2 more
wiley   +1 more source

No Effect of Preoperative Mepolizumab on Early Postoperative Healing After ESS for Severe CRSwNP

open access: yesLaryngoscope Investigative Otolaryngology, Volume 11, Issue 6, December 2026.
ABSTRACT Objective To evaluate postoperative endoscopic mucosal healing 2 weeks after ESS in patients with severe CRSwNP treated with surgery alone versus surgery combined with biologics initiated 2 weeks preoperatively. Methods In this exploratory post hoc analysis, patients with severe CRSwNP were divided into two cohorts: ESS alone and ESS with ...
A. S. Homøe   +7 more
wiley   +1 more source

An unusual phaeoid fungi: Ulocladium, as a cause of chronic allergicfungal sinusitis

open access: yesIranian Journal of Microbiology, 2010
Allergic fungal sinusitis (AFS) has been recognized as an important cause of chronic sinusitis commonly caused by Aspergillus spp. and various dematiaceous fungi like Bipolaris, Alternaria, Curvalaria, and etc.
R Kaur, A Wadhwa, A Gulati, AK Agrawal
doaj  

Clinical Effects of Adjunctive Shoseiryuto Therapy in Refractory Eosinophilic Chronic Rhinosinusitis: A Pilot Retrospective Case Series Focusing on Mucus‐Related Symptoms

open access: yesTraditional &Kampo Medicine, Volume 13, Issue 3, December 2026.
ABSTRACT Aim To evaluate the efficacy and safety of adjunctive shoseiryuto, a traditional Japanese Kampo medicine, in patients with refractory eosinophilic chronic rhinosinusitis (ECRS), with particular attention to mucus‐related symptoms. Methods This retrospective pilot case series was conducted at Osaka Medical and Pharmaceutical University Hospital
Yusuke Kikuoka
wiley   +1 more source

Eosinophilia and Hypereosinophilia: A Practical Approach to Navigating a Broad Differential Diagnosis

open access: yesEuropean Journal of Haematology, Volume 117, Issue 6, Page 1485-1499, December 2026.
ABSTRACT Eosinophilia, defined as an absolute eosinophil count (AEC) of ≥ 0.5 × 109/L, is a frequently encountered finding with a vast spectrum of potential underlying etiologies. Hypereosinophilia (HE) is defined as AEC > 1.5 × 109/L and may become life‐threatening when eosinophil‐induced organ damage occurs, defining the hypereosinophilic syndrome ...
Stijn Wigerinck, Peter Vandenberghe
wiley   +1 more source

Evaluating antioxidant treatment approaches for eosinophilic chronic sinusitis. [PDF]

open access: yesFront Immunol
Kusunoki T   +4 more
europepmc   +1 more source

Sinusitis in HIV-infected patients.

open access: yes, 1997
The purpose of this study is to retrospectively review the clinical, radiographic and laboratory characteristics, the therapy and evolution of sinusitis in HIV-infected patients hospitalized between January 1, 1985 and July 31, 1994.
M. FANTONI   +5 more
core  

Pharmacokinetics and safety of tezepelumab in children with mild, moderate or severe asthma and adolescents with mild‐to‐moderate asthma

open access: yesBritish Journal of Clinical Pharmacology, Volume 92, Issue 11, Page 3819-3830, November 2026.
Abstract Aim Tezepelumab is a human monoclonal antibody that blocks the activity of thymic stromal lymphopoietin and is approved for adolescents and adults with severe asthma. This analysis assessed pharmacokinetics (PK), pharmacodynamics and safety of tezepelumab up to 85 days postdose in adolescents and children.
Anna Lundahl   +14 more
wiley   +1 more source

Home - About - Disclaimer - Privacy